EUmetriosis: Insights Into the Pathogenesis of Endometriosis
ConditionEndometriosis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-56
SponsorUniversité Catholique de Louvain
About this trial
This study investigates epigenetic changes in menstrual effluent and plasma from women with endometriosis to identify potential non-invasive diagnostic biomarkers for the disease.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Premenopausal
In spontaneous menstrual cycle (no hormonal treatments for the last 3 months)
Healthy or with a clear diagnosis of endometriosis via ultrasound, MRI or laparoscopy
Disqualifiers
HIV or Hepatitis positive
Pregnancy
Trial design
Design model
Single group
Treatments tested in this trial
Endometrial biopsy or menstrual cup and blood sample
Procedure/SurgeryEnrolled patients will give their menstrual effluent either via a menstrual cup or via a pipelle biopsy. They will also undergo a blood draw.
Treatment groups
60 Participants
are divided into 1 treatment groupGroup A: Epigenetics characterizationExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Epigenetic analysis
Histone post-translational modifications
Time frame
Throughout the entire study, approximately during 3,5 years2
Epigenetic analysis
miRNA
Time frame
Throughout the entire study, approximately during 3,5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov